Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
863 studies found for:    "Ovarian epithelial cancer"
Show Display Options
Rank Status Study
1 Not yet recruiting Optimisation of Disease Management in Patients With Epithelial Ovarian Cancer in France
Condition: Ovarian Epithelial Cancer
Intervention: Other: Patient with ovarian epithelial cancer
2 Completed Interleukin-12 in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Conditions: Primary Peritoneal Cavity Cancer;   Recurrent Ovarian Epithelial Cancer
Intervention: Biological: recombinant interleukin-12
3 Withdrawn Feasibility Study of Short Term Fondaparinux (Arixtra) in Chemotherapy-Pretreated Ovarian Carcinoma Patients at High Risk of Progression
Condition: Ovarian Carcinoma
Intervention: Drug: Fondaparinux
4 Recruiting Safety and Efficacy Study of Daily SPL-108 Injections In Conjunction With Paclitaxel in Women With Ovarian Cancer
Condition: Ovarian Epithelial Cancer
Intervention: Drug: SPL-108
5 Active, not recruiting Phase II Study DCVAC/OvCa Added to First Line Carboplatin and Paclitaxel Newly Diagnosed Epithelial Ovarian Carcinoma
Conditions: Ovarian Neoplasms;   Ovarian Epithelial Cancer
Interventions: Biological: DCVAC/OvCa with Standard of Care;   Biological: DCVAC/OvCa sequentially chemotherapy;   Drug: Standard of Care
6 Unknown  Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Phase III Randomized Study
Condition: Ovarian Carcinoma
Intervention: Other: timing of surgery
7 Withdrawn Whole Abdomen Radiation in Conjunction With Intraperitoneal Chemotherapy for the Treatment of Small Volume Recurrent Ovarian Carcinoma Limited to the Peritoneal Cavity
Condition: Recurrent Ovarian Carcinoma
Interventions: Drug: Cisplatin;   Radiation: Whole Abdomen Radiotherapy
8 Not yet recruiting p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer
Conditions: Ovarian Epithelial Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Cancer
Interventions: Drug: p53 gene;   Drug: Cisplatin;   Drug: Paclitaxel
9 Unknown  Study on Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin Chemotherapy in Patients With Epithelial Ovarian Cancer
Condition: Epithelial Ovarian Cancer
10 Active, not recruiting Safety, Feasibility and Effect of TTFields (200 kHz) Concomitant With Weekly Paclitaxel in Recurrent Ovarian Carcinoma (INNOVATE)
Condition: Ovarian Carcinoma
Interventions: Device: NovoTTF-100L(O);   Drug: Paclitaxel
11 Terminated
Has Results
A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy
Condition: Epithelial Ovarian Cancer
Interventions: Drug: CAELYX;   Drug: Topotecan HCl
12 Completed Sorafenib Tosylate and Gemcitabine Hydrochloride in Treating Patients With Recurrent Epithelial Ovarian Cancer
Conditions: Recurrent Ovarian Epithelial Cancer;   Recurrent Primary Peritoneal Cavity Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: sorafenib tosylate;   Other: laboratory biomarker analysis
13 Recruiting Impact of Fas/FasL in Chemotherapy Response in Epithelial Ovarian Carcinoma
Condition: Ovarian Carcinoma
14 Not yet recruiting Plasma ctDNA Detection in Diagnosis of Epithelial Ovarian Cancer.
Condition: Epithelial Ovarian Cancer
Intervention: Diagnostic Test: methylation markers screening
15 Completed FES-PET to Determine ER-expression in Epithelial Ovarian Cancer
Condition: Epithelial Ovarian Cancer
Intervention: Other: FES-PET
16 Terminated Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment Strategy
Condition: Ovarian Carcinoma
Intervention: Drug: Cytophosphan, Celecoxib, Methotrexate
17 Completed Green Tea Intake for the Maintenance of Complete Remission in Women With Advanced Ovarian Carcinoma
Condition: Ovarian Carcinoma
Intervention: Dietary Supplement: Double-Brewed Green Tea
18 Completed Live After an Epithelial Ovarian Cancer: Multidisciplinary Assessment of Effects and Long-term Remission in Patients Needs.
Condition: Epithelial Ovarian Cancer
Intervention: Other: Gynecological consultation
19 Unknown  Safety of Active Immunotherapy in Subjects With Ovarian Cancer
Condition: Ovarian Epithelial Cancer
Intervention: Biological: Procure
20 Recruiting REGorafenib vsTamoxifen in Patients With Platinum-sensitive OVARian Carcinoma and Isolated Biological Progression
Condition: Ovarian Carcinoma
Interventions: Drug: Tamoxifen;   Drug: Regorafenib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.